Ribavirin plasma concentration predicts sustained virological response to peginterferon Alfa 2a plus ribavirin in previously treated HCV-HIV-coinfected patients.
about
Plasma Ribavirin Trough Concentrations at Week 4 Predict Hepatitis C Virus (HCV) Relapse in HIV-HCV-Coinfected Patients Treated for Chronic Hepatitis CUsing pharmacokinetic and viral kinetic modeling to estimate the antiviral effectiveness of telaprevir, boceprevir, and pegylated interferon during triple therapy in treatment-experienced hepatitis C virus-infected cirrhotic patientsErythrocyte and plasma ribavirin concentrations in the assessment of early and sustained virological responses to pegylated interferon-alpha 2a and ribavirin in patients coinfected with hepatitis C virus and HIV.
P2860
Ribavirin plasma concentration predicts sustained virological response to peginterferon Alfa 2a plus ribavirin in previously treated HCV-HIV-coinfected patients.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Ribavirin plasma concentration ...... d HCV-HIV-coinfected patients.
@en
Ribavirin plasma concentration ...... d HCV-HIV-coinfected patients.
@nl
type
label
Ribavirin plasma concentration ...... d HCV-HIV-coinfected patients.
@en
Ribavirin plasma concentration ...... d HCV-HIV-coinfected patients.
@nl
prefLabel
Ribavirin plasma concentration ...... d HCV-HIV-coinfected patients.
@en
Ribavirin plasma concentration ...... d HCV-HIV-coinfected patients.
@nl
P2093
P50
P1476
Ribavirin plasma concentration ...... d HCV-HIV-coinfected patients.
@en
P2093
Didier Neau
Dominique Breilh
Hervé Fleury
Jean-Marie Ragnaud
Marie-Claude Saux
Michel Dupon
Sarah Djabarouti
P304
P356
10.1097/QAI.0B013E3181B62858
P407
P577
2009-11-01T00:00:00Z